The popularity of Sildenafil initially fueled a surge for the drug industry, nevertheless recent changes present a uncertain outlook for those considering a stake. Lower-cost competitors are reducing revenue, and https://larissaxbba503536.getblogs.net/73775636/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-investment